The Pharmacist’s Role in Implementing the New Pain, Agitation, and Delirium Guidelines in the Critical Care Setting
Activity Overview
Please read the following information about this continuing pharmacy education (CPE) activity before accessing the presentations using the link located at the bottom of this page.
Release Date: February 15, 2013 Expiration Date: March 3, 2014
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEU) of continuing pharmacy education credit (ACPE activity #0204-0000-12-435-H01-P).
Methods and Format
This is an online activity consisting of audio and slides, an assessment (post-test), and a course evaluation. Participants should claim continuing education credit for this internet-based educational activity only if they have not claimed credit for the live activity. Participants must view the entire presentation, take the activity assessment, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 1 hour. This activity is provided free of charge.
Target Audience
This continuing pharmacy education activity was planned to meet the needs of all pharmacists, especially those who are interested in the care of critically ill patients.
Activity Content
This educational activity will begin with a review of key changes to the Society of Critical Care Medicine’s pain, agitation, and delirium guidelines. Identification, prevention, and treatment of pain, agitation, and delirium in the critically ill patient will also be explained. The activity will conclude by demonstrating strategies that pharmacists can use to implement the new recommendations in the critical care setting.
Learning Objectives
After attending this application-based educational activity, participants should be able to
- Differentiate between the 2002 and the soon-to-be released pain, agitation, and delirium (PAD) guidelines from the Society of Critical Care Medicine.
- Adapt the PAD guidelines into prevention and treatment plans for pain, agitation, and delirium in the critically ill patient.
- Define the pharmacist’s role in implementing the revised PAD guidelines in the critical care setting.
Faculty
Associate Professor, School of Pharmacy
Northeastern University
Special and Scientific Staff, Division of Pulmonary, Critical Care and Sleep Medicine
Tufts Medical Center
Adjunct Associate Professor, School of Medicine
Tufts University
Boston, Massachusetts
John W. Devlin, Pharm.D., FCCM, FCCP, is Associate Professor of Pharmacy at Northeastern University and Adjunct Associate Professor of Medicine at Tufts University in Boston. At Tufts Medical Center, Dr. Devlin is a member of the special and scientific staff in the Division of Pulmonary, Critical Care and Sleep Medicine, and he serves four months annually as a critical care pharmacist in the medical intensive care unit. Dr. Devlin directs a two-year critical care pharmacy fellowship program that is currently training its fourth candidate, and he frequently involves Northeastern University pharmacy students in his research.
Dr. Devlin earned his Bachelor of Science in Pharmacy and Doctor of Pharmacy degrees at the University of Toronto in Ontario, Canada. He completed a pharmacy practice residency at London Health Sciences Centre in London, Ontario, Canada and a critical care pharmacy fellowship at Henry Ford Hospital in Detroit, Michigan.
Dr. Devlin is a fellow of the American College of Critical Care Medicine and the American College of Clinical Pharmacy. He has published more than 50 peer-reviewed original research articles and more than 40 review papers and editorials, authored 20 textbook chapters, and presented more than 80 research abstracts at national and international pharmacy and critical care scientific meetings, primarily in the field of critical care pharmacotherapy. He is a member of the editorial boards of both Critical Care Medicine and Pharmacotherapy. Dr. Devlin’s federally-funded research program is primarily focused on the detection, prevention, and treatment of delirium in the intensive care unit and the use and assessment of sedation in the critically ill. He is frequently invited to lecture on his research at national and international critical care and pharmacy meetings.
Professor, School of Medicine
Tufts University
PGY2 Critical Care Residency Program Director
Clinical Pharmacist, Critical Care
Maine Medical Center
Portland, Maine
Gilles L. Fraser, Pharm.D., FCCM, is Professor, School of Medicine, Tufts University, and Clinical Pharmacist, Critical Care, at the Maine Medical Center in Portland. Dr. Fraser also serves as program director for the PGY2 critical care residency program.
Dr. Fraser earned his Bachelor of Science in Pharmacy from the University of Connecticut in Storrs and Doctor of Pharmacy degree from the University of Minnesota in Minneapolis.
Dr. Fraser is a fellow of the Society of Critical Care Medicine. He served on the editorial board of Critical Care Research and was a contributing editor for Critical Care Therapeutics and Hospital Pharmacy. Dr. Fraser has published extensively in the area of critical care medicine in the form of original research articles, review papers and editorials, textbook chapters, and research abstracts at national and international pharmacy and critical care scientific meetings.
Dr. Fraser has received numerous awards and honors, including presidential citations from the Society of Critical Care Medicine (2013, 2006, and 2000), Maine Society of Health-System Pharmacists Pharmacy Practice Award (2010), and the Society of Critical Care Medicine Internal Medicine Award (2007).
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.
All faculty and planners for ASHP Advantage education activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests. ASHP Advantage identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.
The faculty and planners report the following relationships:
John W. Devlin, Pharm.D., FCCP, FCCM
Dr. Devlin declares that he has received research grant support from Hospira.
Gilles L. Fraser, Pharm.D., FCCM
Dr. Fraser declares that he has no relationships pertinent to this activity.
Susan R. Dombrowski, M.S., B.S.Pharm.
Ms. Dombrowski declares that she has no relationships pertinent to this activity.
Kristi N. Hofer, Pharm.D.
Dr. Hofer declares that she has no relationships pertinent to this activity.
ASHP staff has no relevant financial relationships to disclose.
This activity is supported by an educational grant from Hospira, Inc.
Agenda (60 minutes total)*
Overview of the New Pain, Agitation, and Delirium (PAD) Guidelines
John W. Devlin, Pharm.D., FCCP, FCCM
(25 minutes)
Role of the Pharmacist in Implementing the New PAD Guidelines
Gilles L. Fraser, Pharm.D., FCCM
(25 minutes)
Questions and Answers
All Faculty
(optional, 10 minutes)
*Allow additional time to complete the assessment and evaluation.
Download Published Guidelines
- Executive Summary of Guidelines
Am J Health-Syst Pharm. 2013; 70:53-8. - Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit (Subscription required for full text)
Download Assessment and Handout
Print the assessment (post-test) and handout of slides for your reference; however, your assessment must be submitted online.
Process CE
When you reach the end of the activity, follow instructions to complete the online process (i.e., take assessment test and complete evaluation) and obtain CE credit.
